- INTERMITTENT CLAUDICATION (ANGINA CRURIS). Samuels, Saul S. // Angiology;Aug1958, Vol. 9 Issue 4, p245
Provides information about intermittent claudication. Cause and pathogenesis; Signs and symptoms; Diagnosis and treatment;
- Successful outcome with early renal transplantation following treatment of encapsulating peritoneal sclerosis. Ward, Frank; Moran, Ann-Marie; Minhas, Malik; Watson, Alan // NDT Plus;Oct2010, Vol. 3 Issue 5, p477
Encapsulating peritoneal sclerosis (EPS) is a rare complication of peritoneal dialysis (PD) associated with cocooning of the bowel within a sheath of fibrous tissue causing obstruction. Uncertainty remains regarding the aetiology, pathogenesis and optimal treatment. The current management of EPS...
- DISCUSSION. Andreozzi, G. M. // Angiology;Nov1998, Vol. 49 Issue 11, p895
Discusses the background in treating severe claudication with prostanoids. Pathophysiology of severe claudication; Capacity of prostanoids to restore the microcirculatory autoregulation; Opening of the possibility of increasing the availability of endovascular procedures.
- Treatment of intermittent claudication. Karthikeyan, G.; Eikelboom, John W. // BMJ: British Medical Journal (Overseas & Retired Doctors Edition;3/21/2009, p671
The authors reflect on methods which are used to treat intermittent claudication. They suggest that any methods that are used should improve the patient's symptoms and decrease the risk of cardiovascular problems. They argue that the most important goal of medical treatment in patients with...
- Efficacy of Cilostazol for Intermittent Claudication. Apgar, Barbara // American Family Physician;2/15/2000, Vol. 61 Issue 4, p1124
Discusses the study `A New Pharmacological Treatment for Intermittent Claudication: Results of a Randomized, Multicenter Trial,' by H.G. Beebe and colleagues published in the September 27, 1999 issue of the `Archives of Internal Medicine.'
- Effects of Pentoxifylline on Severe Intermittent Claudication. Reich, Theobald; Gilings, Dennis // Angiology;Sep1987, Vol. 38 Issue 9, p651
Pentoxifylline has been shown to improve treadmill walking distances under blinded, controlled conditions in patients with intermittent claudication. From the pooled data of a blinded, controlled, randomized, multicenter trial, the data from all enrolled patients with severe claudication (< 70 m...
- Comparison of Safety and Efficacy of Buflomedil and Naftidrofuryl in the Treatment of Intermittent Claudication. Rosas, Guillermo; Cerdeyra, Cristina; Lucas, Miguel A.; Parano, Jorge R.; Villa, Juan J. // Angiology;May1981, Vol. 32 Issue 5, p291
In a group of 58 patients with peripheral arteriopathies, we have studied efficacy and safety of buflomedil hydrochloride and naftidrofuryl. Both drugs have been shown to have vasoactive properties evaluated through walking capacity and time of hyperemia. According to our results, buflomedil is...
- A focus on risk factor management. Belch, Jill J. F.; Creager, Mark A. // Vascular Medicine;2004, Vol. 9 Issue 3, p169
This article reports that peripheral arterial disease (PAD) and its most common manifestation, intermittent claudication (IC), are associated with considerable morbidity and mortality. The patient with PAD has well-documented risk factors for atherosclerosis. Because of these, combined with the...
- TREATMENT OF INTERMITTENT CLAUDICATION. Samuels, Saul S. // Angiology;Apr1957, Vol. 8 Issue 2, p201
A preliminary report is offered relative to the beneficial effect of a tranquilizing drug, phenoglycodol, in the relief of the disabling symptom of intermittent claudication.